Literature DB >> 26123392

Inhibition of SH2-domain-containing inositol 5-phosphatase (SHIP2) ameliorates palmitate induced-apoptosis through regulating Akt/FOXO1 pathway and ROS production in HepG2 cells.

Sattar Gorgani-Firuzjaee1, Khosrow Adeli2, Reza Meshkani3.   

Abstract

The serine-threonine kinase Akt regulates proliferation and survival by phosphorylating a network of protein substrates; however, the role of a negative regulator of the Akt pathway, the SH2-domain-containing inositol 5-phosphatase (SHIP2) in apoptosis of the hepatocytes, remains unknown. In the present study, we studied the molecular mechanisms linking SHIP2 expression to apoptosis using overexpression or suppression of SHIP2 gene in HepG2 cells exposed to palmitate (0.5 mM). Overexpression of the dominant negative mutant SHIP2 (SHIP2-DN) significantly reduced palmitate-induced apoptosis in HepG2 cells, as these cells had increased cell viability, decreased apoptotic cell death and reduced the activity of caspase-3, cytochrome c and poly (ADP-ribose) polymerase. Overexpression of the wild-type SHIP2 gene led to a massive apoptosis in HepG2 cells. The protection from palmitate-induced apoptosis by SHIP2 inhibition was accompanied by a decrease in the generation of reactive oxygen species (ROS). In addition, SHIP2 inhibition was accompanied by an increased Akt and FOXO-1 phosphorylation, whereas overexpression of the wild-type SHIP2 gene had the opposite effects. Taken together, these findings suggest that SHIP2 expression level is an important determinant of hepatic lipoapotosis and its inhibition can potentially be a target in treatment of hepatic lipoapoptosis in diabetic patients.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Akt; Apoptosis; FOXO-1; HepG2; Lipoapoptosis; Liver; Palmitate; ROS; SHIP2

Mesh:

Substances:

Year:  2015        PMID: 26123392     DOI: 10.1016/j.bbrc.2015.06.134

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  8 in total

1.  Palmitic acid triggers cell apoptosis in RGC-5 retinal ganglion cells through the Akt/FoxO1 signaling pathway.

Authors:  Panshi Yan; Shu Tang; Haifeng Zhang; Yuanyuan Guo; Zhiwen Zeng; Qiang Wen
Journal:  Metab Brain Dis       Date:  2016-12-07       Impact factor: 3.584

2.  Inhibition of SHIP2 in CD2AP-deficient podocytes ameliorates reactive oxygen species generation but aggravates apoptosis.

Authors:  Pauliina Saurus; Tuomas A Tolvanen; Sonja Lindfors; Sara Kuusela; Harry Holthöfer; Eero Lehtonen; Sanna Lehtonen
Journal:  Sci Rep       Date:  2017-09-06       Impact factor: 4.379

Review 3.  PI3K/SHIP2/PTEN pathway in cell polarity and hepatitis C virus pathogenesis.

Authors:  Aline Awad; Ama Gassama-Diagne
Journal:  World J Hepatol       Date:  2017-01-08

4.  Upregulation of SHIP2 participates in the development of breast cancer via promoting Wnt/β-catenin signaling.

Authors:  Juan Zhou; Manman Di; Hui Han
Journal:  Onco Targets Ther       Date:  2019-08-30       Impact factor: 4.147

5.  IRTKS Promotes Insulin Signaling Transduction through Inhibiting SHIP2 Phosphatase Activity.

Authors:  Chongchao Wu; Xiaofang Cui; Liyu Huang; Xueying Shang; Binghao Wu; Na Wang; Kunyan He; Zeguang Han
Journal:  Int J Mol Sci       Date:  2019-06-11       Impact factor: 5.923

6.  Ebselen enhances insulin sensitivity and decreases oxidative stress by inhibiting SHIP2 and protects from inflammation in diabetic mice.

Authors:  Zydrune Polianskyte-Prause; Tuomas A Tolvanen; Sonja Lindfors; Kanta Kon; Laura C Hautala; Hong Wang; Tsutomu Wada; Hiroshi Tsuneki; Toshiyasu Sasaoka; Sanna Lehtonen
Journal:  Int J Biol Sci       Date:  2022-02-14       Impact factor: 6.580

7.  Gastrodin Ameliorates Acute Rejection via IRE1α/TRAF2/NF-κB in Rats Receiving Liver Allografts.

Authors:  Fangchao Yuan; Xuesong Xu; Yakun Wu; Shigang Duan; Hao Wu
Journal:  Biomed Res Int       Date:  2019-11-20       Impact factor: 3.411

8.  SHIP2 inhibition alters redox-induced PI3K/AKT and MAP kinase pathways via PTEN over-activation in cervical cancer cells.

Authors:  Abdelhalim Azzi
Journal:  FEBS Open Bio       Date:  2020-10-01       Impact factor: 2.792

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.